New findings from the WISDOM study (SABCS 2025) suggest that risk-based breast cancer screening is safe and may reduce advanced-stage cancers. However, real-world challenges remain—particularly around biopsy rates and patient adherence. What’s changing?Risk assessment...
Stereotactic biopsies are used when breast abnormalities, such as microcalcifications, are visible only on mammography and not on ultrasound. In these cases, using 3D mammographic guidance, radiologists can precisely locate and sample these very small areas that...
Welcome to Smarter Mammography! In today’s mammography market, one size no longer fits all. Healthcare systems across Latin America and Eurasia operate under very different clinical, regulatory, and budget realities — and imaging technology must be flexible enough to...